Tissue factor expression correlates with disease‐specific survival in patients with node‐negative muscle‐invasive bladder cancer
Authors:
Open Access
- 25 January 2008
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 122 (7) , 1592-1597
Abstract
Tissue factor (TF), a transmembrane glycoprotein responsible for initiating the extrinsic pathway of blood coagulation plays a key role in cancer growth, metastasis and angiogenesis. Various studies have demonstrated the prognostic potential of TF expression in several cancers. However, its role in bladder cancer is unclear. This study evaluated the prognostic potential of TF expression in muscle‐invasive bladder tumors from patients treated with radical cystectomies. Immunohistochemical staining using a monoclonal antibody (mAb) anti‐TF was carried out on sections of tissue microarray blocks containing cores of muscle‐invasive bladder tumors (4 cores/tumor) from 218 patients. The intensity of the staining was evaluated on a scale from 0 to 3 by two independent observers who were both unaware of the clinicopathological characteristics of the samples. TF was expressed in 77.6% of tumors, independently from baseline characteristics (age, gender, stage and grade) as assessed using the χ2 and Student t tests. During follow‐up (median: 2.6 years), 45.4% of the patients died from the progression of their cancer. Kaplan–Meier survival showed that among the 103 patients with node‐negative (N0) transitional cell carcinoma (TCC), those with TF‐positive tumors had shorter bladder cancer‐specific survival (p = 0.0276). Moreover, multivariate Cox regression analysis showed they had a 3.15‐fold greater risk of dying from bladder cancer (95% CI: 1.1–9.0; p = 0.032). In conclusion, TF expression was an independent predictor of disease‐specific survival in N0 muscle‐invasive TCCs treated by radical cystectomy and therefore, might help identify patients at higher risk of disease progression. These patients could potentially benefit from adjuvant chemotherapy.Keywords
This publication has 22 references indexed in Scilit:
- Tissue Factor in Cancer and Angiogenesis: The Molecular Link between Genetic Tumor Progression, Tumor Neovascularization, and Cancer CoagulopathySeminars in Thrombosis and Hemostasis, 2006
- Preoperative Serum Tissue Factor Levels Are an Independent Prognostic Factor in Patients With Ovarian CarcinomaJournal of Clinical Oncology, 2006
- Prognostic Significance of Tissue Factor in Pancreatic Ductal AdenocarcinomaClinical Cancer Research, 2005
- Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancerProceedings of the National Academy of Sciences, 2001
- Urinary tissue factor levels in patients with bladder andprostate cancerEuropean Journal of Surgical Oncology, 2000
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996
- Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.Proceedings of the National Academy of Sciences, 1995
- Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.Journal of Clinical Investigation, 1994
- Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.Proceedings of the National Academy of Sciences, 1992
- Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibodyThrombosis Research, 1990